165 related articles for article (PubMed ID: 2481151)
1. Immunohistochemical spectrum of malignant melanoma. The common presence of keratins.
Miettinen M; Franssila K
Lab Invest; 1989 Dec; 61(6):623-8. PubMed ID: 2481151
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma with neuroendocrine differentiation: clinical, histological, immunohistochemical and ultrastructural features of three cases.
Eyden B; Pandit D; Banerjee SS
Histopathology; 2005 Oct; 47(4):402-9. PubMed ID: 16178895
[TBL] [Abstract][Full Text] [Related]
3. S100 immunophenotypes of uveal melanomas.
Kan-Mitchell J; Rao N; Albert DM; Van Eldik LJ; Taylor CR
Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1492-6. PubMed ID: 1696942
[TBL] [Abstract][Full Text] [Related]
4. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.
Romano RC; Carter JM; Folpe AL
Mod Pathol; 2015 Aug; 28(8):1033-42. PubMed ID: 26022451
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
[TBL] [Abstract][Full Text] [Related]
6. A detailed immunohistochemical analysis of cerebellar hemangioblastoma: an undifferentiated mesenchymal tumor.
Frank TS; Trojanowski JQ; Roberts SA; Brooks JJ
Mod Pathol; 1989 Nov; 2(6):638-51. PubMed ID: 2479946
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of intermediate filaments in squamous cell carcinomas of upper aerodigestive tract before and after radiation and chemotherapy.
Fischer HP; Wallner F; Maier H; Weber K; Osborn M; Altmannsberger M
Lab Invest; 1989 Oct; 61(4):433-9. PubMed ID: 2477642
[TBL] [Abstract][Full Text] [Related]
8. Postembedding immunogold electron microscopy for S100, tubulin, and cytoskeletal proteins in an amelanotic malignant melanoma.
Hearn SA; Kontozoglou TE
Mod Pathol; 1989 Jan; 2(1):46-54. PubMed ID: 2922390
[TBL] [Abstract][Full Text] [Related]
9. HMB-45 detection in adenocarcinomas.
Hancock C; Allen BC; Herrera GA
Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma.
Tanabe K; Amoh Y; Kanoh M; Takasu H; Sakai N; Sato Y; Katsuoka K
Eur J Dermatol; 2010; 20(3):283-8. PubMed ID: 20156773
[TBL] [Abstract][Full Text] [Related]
11. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
Karbowniczek M; Chosia M; Domagała W
Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
[TBL] [Abstract][Full Text] [Related]
12. Presence of fibroblast-type intermediate filaments (vimentin) and absence of neurofilaments in pigmented nevi and malignant melanomas.
Miettinen M; Lehto VP; Virtanen I
J Cutan Pathol; 1983 Jun; 10(3):188-92. PubMed ID: 6190849
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
14. Malicious masquerade: myxoid melanoma.
Hitchcock MG; White WL
Semin Diagn Pathol; 1998 Aug; 15(3):195-202. PubMed ID: 9711669
[TBL] [Abstract][Full Text] [Related]
15. Fine needle aspiration biopsy of metastatic melanoma. A morphologic analysis of 174 cases.
Perry MD; Gore M; Seigler HF; Johnston WW
Acta Cytol; 1986; 30(4):385-96. PubMed ID: 3461649
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of N-cadherin distinguishes a subset of metastasizing desmoplastic melanomas.
Attis MG; Burchette JL; Selim MA; Pham T; Soler AP
Hum Pathol; 2006 Jul; 37(7):899-905. PubMed ID: 16784991
[TBL] [Abstract][Full Text] [Related]
17. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas.
de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G
Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901
[TBL] [Abstract][Full Text] [Related]
18. Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas.
Zarbo RJ; Gown AM; Nagle RB; Visscher DW; Crissman JD
Mod Pathol; 1990 Jul; 3(4):494-501. PubMed ID: 1699224
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
20. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
